Background pattern
STEROKORT

STEROKORT

Ask a doctor about a prescription for STEROKORT

5.0(2)
Doctor

Tomasz Grzelewski

Dermatology21 years of experience

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
CameraBook a video appointment
€80
Today20:10
Today20:35
Today21:00
Today21:25
Today21:50
More times
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use STEROKORT

INSTRUCTIONS for medical use of the medicinal product KLIMAKTOPLAN (KLIMAKTOPLAN®)

Composition

active substances: 1 tablet contains: Cimicifuga D2 25 mg, Ignatia D3 25 mg, Sepia D2 25 mg, Sanguinaria D6 25 mg; auxiliary substances: lactose monohydrate, magnesium stearate, wheat starch.

Pharmaceutical form

Tablets.

Main physical and chemical properties

gray, biconvex tablets with a beveled edge, sometimes slightly speckled.

Pharmacotherapeutic group

Complex homeopathic preparation. Other preparations for the treatment of gynecological diseases. ATC code G02CX.

Pharmacological properties

Klimaktoplan contains four ingredients that determine the effect of the preparation. Cimicifuga affects the hypothalamus, eliminating or weakening hot flashes, nervous excitement, and depression. Sepia regulates the common functions of hormones of the adrenal cortex, sex organs, and pituitary gland. Sepia, like Ignatia, primarily acts on mental reactions, but it also affects flashes of heat, hot flashes, headaches, and a state of weakness. Sanguinaria is particularly effective in hot flashes accompanied by transient flushing and rapid heartbeat, as well as in migraine-type headaches.

Therefore, Klimaktoplan, due to the combination of specific ingredients, treats a complex of symptoms typical of the climacteric period. Thanks to its good tolerability, Klimaktoplan can be taken for a long time.

Clinical characteristics

Indications

Climacteric disorders: hot flashes, increased sweating, feeling of heartbeat, dizziness, itching, internal anxiety, sleep disturbances, depressive state, nervous excitability.

Contraindications

Increased sensitivity to the active substances or to any of the auxiliary substances of the medicinal product.

Interaction with other medicinal products and other types of interactions

Not known to date.

The use of a homeopathic medicinal product does not exclude the use of other medicinal products.

Patients should consult a doctor if they are taking or have recently taken any other medications, including medicinal products that can be purchased without a prescription.

Note. The action of homeopathic medicinal products may vary depending on general negative factors associated with harmful habits (stimulants: for example, coffee or tea, alcohol, smoking).

Special instructions

It is necessary to consult a doctor if the condition has not improved or worsened, or if additional complaints have appeared.

The medicinal product contains lactose, so patients with rare hereditary forms of galactose intolerance, lactase deficiency, or glucose-galactose malabsorption syndrome should not use it.

One of the auxiliary substances that make up the preparation is wheat starch. In connection with this, tablets should not be used by patients with increased sensitivity or intolerance to gluten.

Use during pregnancy or breastfeeding

Not used during pregnancy and breastfeeding.

Ability to affect the speed of reaction when driving vehicles or other mechanisms

Does not affect.

Method of administration and dosage

Take 1-2 tablets 3 times a day. The maximum daily dose is 6 tablets. Tablets should be taken 30 minutes before meals or 30 minutes after meals, slowly dissolving in the oral cavity. If necessary, tablets can be dissolved in a small amount of water. In case of improvement, the dosage should be reduced. Klimaktoplan should be used for at least 3 months. Treatment can be extended if necessary.

Children

Not used in children.

Overdose

Overdose has not been observed.

Adverse reactions

When using the preparation, hypersensitivity reactions are possible, menstrual and nasal bleeding may occur, or the frequency of menstrual bleeding may increase.

Note. When using homeopathic medicinal products, a temporary worsening of existing disease symptoms (primary worsening) is possible. In this case, the use of the preparation should be stopped and a doctor should be consulted.

In case of any adverse reactions, you should consult a doctor. This applies to all possible side effects, including those not described in this instruction.

Shelf life

5 years.

Do not use after the expiration date stated on the packaging.

Storage conditions

Store at a temperature not exceeding 25 ºC in a dry, inaccessible place for children.

Packaging

20 tablets in a blister pack; 3 or 5 blister packs in a cardboard box.

Release category

Without a prescription.

Manufacturer

Dr. Gustav Klein GmbH & Co. KG

Location of the manufacturer and address of the place of its activity

Steinenfeld 3, 77736 Zell am Harmersbach, Germany

Alternatives to STEROKORT in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to STEROKORT in Spain

Dosage form: TOPICAL SOLUTION, 1 mg/ml
Active substance: methylprednisolone aceponate
Manufacturer: Skin Care Pharma Gmbh
Prescription required
Dosage form: EMULSION, 1 mg/g
Active substance: methylprednisolone aceponate
Prescription required
Dosage form: EMULSION, 1 mg/g
Active substance: methylprednisolone aceponate
Manufacturer: Isdin S.A.
Prescription required
Dosage form: CREAM, 1 mg/g
Active substance: methylprednisolone aceponate
Manufacturer: Isdin S.A.
Prescription required
Dosage form: EMULSION, 1 mg/g
Active substance: methylprednisolone aceponate
Prescription required
Dosage form: CREAM, 1 mg/g
Active substance: methylprednisolone aceponate
Manufacturer: Italfarmaco S.A.
Prescription required

Alternative to STEROKORT in Poland

Dosage form: Cream, 1 mg/g
Active substance: methylprednisolone aceponate
Marketing authorisation holder (MAH): Italfarmaco S.A.
Prescription required
Dosage form: Cream, 1 mg/g
Active substance: methylprednisolone aceponate
Marketing authorisation holder (MAH): LEO Pharma A/S
Prescription required
Dosage form: Ointment, 1 mg/g
Active substance: methylprednisolone aceponate
Marketing authorisation holder (MAH): LEO Pharma A/S
Prescription required
Dosage form: Cream, 1 mg/g
Active substance: methylprednisolone aceponate
Marketing authorisation holder (MAH): LEO Pharma A/S
Prescription required
Dosage form: Cream, 1 mg/g
Active substance: methylprednisolone aceponate
Marketing authorisation holder (MAH): LEO Pharma A/S
Prescription required
Dosage form: Emulsion, 1 mg/g
Active substance: methylprednisolone aceponate
Manufacturer: Paul W. Beyvers GmbH
Prescription required

Online doctors for STEROKORT

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for STEROKORT – subject to medical assessment and local rules.

5.0(2)
Doctor

Tomasz Grzelewski

Dermatology21 years of experience

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
CameraBook a video appointment
€80
Today20:10
Today20:35
Today21:00
Today21:25
Today21:50
More times
5.0(19)
Doctor

Anna Moret

Dermatology19 years of experience

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for:

  • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis.
  • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis.
  • Pediatric skin problems — from newborns to adolescents.
  • Sexually transmitted infections (STIs) and dermatovenereology.
  • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments.
  • Skin allergies and hypersensitivity reactions.
  • Mole checks, lesion evaluation, and skin cancer screening.
  • Skincare advice and personalised cosmeceutical routines.

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

CameraBook a video appointment
€55
January 608:15
January 709:00
January 709:30
January 909:00
January 909:30
More times

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2026 Oladoctor. All rights reserved.
VisaMastercardStripe